Skip to search formSkip to main contentSkip to account menu

MK 0476

Known as: MK-0476 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (5)

AcetatesAcetic Acid EstersLeukotriene AntagonistsQuinolines
Singulairmontelukast sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
69 Evaluation of the safety profile of montelukast (MK-0476) in pediatric patients aged 2 to 5 years
1998
1998
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.
1998
1998
A novel photoaffinity probe for the LTD4 receptor.
1998
1998
Effect of Montelukast on Single‐Dose Theophylline Pharmacokinetics
The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist in development for treatment of asthma, on… 
1997
1997
CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type.
A number of peptido-leukotriene antagonists coming from a variety of different structural classes have been developed over the… 
1997
1997
Montelukast (MK-0476)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)